Genetic Technologies Ltd (GTG)

Sydney
Currency in AUD
0.039
0.000(0.00%)
Closed·
GTG Scorecard
Full Analysis
Quickly burning through cash
Earnings results expected in 5 days
Fair Value
Day's Range
0.0390.039
52 wk Range
0.0360.134
Key Statistics
Edit
Bid/Ask
0.039 / 0.039
Prev. Close
0.039
Open
0.039
Day's Range
0.039-0.039
52 wk Range
0.036-0.134
Volume
-
Average Vol. (3m)
10.07K
1-Year Change
-65.99%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GTG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility
Show more

Genetic Technologies Ltd Company Profile

Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people’s health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through EasyDNA, AffinityDNA, and GeneType/Corporate segments. It offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. The company also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, it offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, type 2 diabetes, pancreatic cancer, melanoma, and atrial fibrillation. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. It has research and collaboration agreements with the University of Melbourne for the development and commercialization of a novel colorectal cancer risk assessment test; Memorial Sloan Kettering Cancer Center of New York and University of Cambridge, that assess the conflict among BRCA mutation carriers considering preventive surgery; and research collaboration with Harvard University, Ohio State University, and Washington University. The company was incorporated in 1987 and is headquartered in Prahran, Australia.

Compare GTG to Peers and Sector

Metrics to compare
GTG
Peers
Sector
Relationship
P/E Ratio
−0.5x−0.6x−0.5x
PEG Ratio
−0.02−0.030.00
Price / Book
3.1x2.6x2.6x
Price / LTM Sales
0.6x4.3x2.9x
Upside (Analyst Target)
-85.2%64.0%
Fair Value Upside
Unlock13.2%9.4%Unlock

Earnings

Latest Release
Feb 28, 2025
EPS / Forecast
-0.04 / --
Revenue / Forecast
4.80M / --
EPS Revisions
Last 90 days

FAQ

What Is the Genetic Technologies Ltd (GTG) Stock Price Today?

The Genetic Technologies Ltd stock price today is 0.039

What Stock Exchange Does Genetic Technologies Ltd Trade On?

Genetic Technologies Ltd is listed and trades on the Sydney stock exchange.

What Is the Stock Symbol for Genetic Technologies Ltd?

The stock symbol for Genetic Technologies Ltd is "GTG."

What Is the Genetic Technologies Ltd Market Cap?

As of today, Genetic Technologies Ltd market cap is 5.67M.

What is Genetic Technologies Ltd Earnings Per Share?

The Genetic Technologies Ltd EPS is -0.09.

What Is the Next Genetic Technologies Ltd Earnings Date?

Genetic Technologies Ltd will release its next earnings report on Apr 28, 2025.

From a Technical Analysis Perspective, Is GTG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.